204 related articles for article (PubMed ID: 32638368)
1. The Arabic Urticaria Activity Score and Chronic Urticaria Quality of Life Questionnaire: validation and correlations.
Tawil S; Irani C; Kfoury R; Salameh P; Baiardini I; Weller K; Maurer M; Ezzedine K
Int J Dermatol; 2020 Aug; 59(8):893-901. PubMed ID: 32638368
[TBL] [Abstract][Full Text] [Related]
2. Adaptation and validation of the Bengali version of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL).
Dhabal A; Mondal H; Mondal S; Baiardini I; Chakraborty SS; Chakraborty T; Podder I
Indian J Dermatol Venereol Leprol; 2023; 89(3):385-392. PubMed ID: 36331856
[TBL] [Abstract][Full Text] [Related]
3. Psychometric properties of the portuguese version of the chronic urticaria quality of life questionnaire (CU-Q
Ferreira PL; Gonçalo M; Ferreira JA; Costa AC; Todo-Bom A; Abreu CL; Travassos AR; Andrade P; Baiardini I; Canonica GW
Health Qual Life Outcomes; 2019 Dec; 17(1):190. PubMed ID: 31888747
[TBL] [Abstract][Full Text] [Related]
4. The persian version of the chronic urticaria quality of life questionnaire: factor analysis, validation, and initial clinical findings.
Tavakol M; Mohammadinejad P; Baiardini I; Braido F; Gharagozlou M; Aghamohammadi A; Nabavi M; Dabbaghzade A; Tavakol Z; Afarideh M; Rezaei N
Iran J Allergy Asthma Immunol; 2014 Aug; 13(4):278-85. PubMed ID: 24659164
[TBL] [Abstract][Full Text] [Related]
5. Minimal clinical important difference (MCID) of the Thai Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL).
Kulthanan K; Chularojanamontri L; Tuchinda P; Rujitharanawong C; Baiardini I; Braido F
Asian Pac J Allergy Immunol; 2016 Jun; 34(2):137-45. PubMed ID: 27007835
[TBL] [Abstract][Full Text] [Related]
6. Chinese version of the chronic urticaria quality of life questionnaire: cultural adaptation, factor analysis, assessment of reliability and validity.
Zhao Z; Zhang C; Jiang Y; Peng C; Zhu W; Zhao S; Chen X; Li J
Arch Dermatol Res; 2022 Nov; 314(9):847-855. PubMed ID: 34739561
[TBL] [Abstract][Full Text] [Related]
7. Adaptation and Validation of the Israeli Version of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL).
Kessel A; Graif Y; Vadasz Z; Schichter-Konfino V; Almog M; Cohen S; Teplitski V; Stein N; Baiardini I; Maurer M; Toubi E
Isr Med Assoc J; 2016 Aug; 18(8):461-465. PubMed ID: 28471576
[TBL] [Abstract][Full Text] [Related]
8. Psychometric properties of the Spanish version of the once-daily Urticaria Activity Score (UAS) in patients with chronic spontaneous urticaria managed in clinical practice (the EVALUAS study).
Jauregui I; Gimenez-Arnau A; Bartra J; Labrador-Horrillo M; de Frutos JO; Silvestre JF; Sastre J; Velasco M; Ferrer M; Ballesteros C; Valero A
Health Qual Life Outcomes; 2019 Jan; 17(1):23. PubMed ID: 30704532
[TBL] [Abstract][Full Text] [Related]
9. Adaptation and validation of the Spanish version of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL).
Valero A; Herdman M; Bartra J; Ferrer M; Jáuregui I; Dávila I; del Cuvillo A; Montoro J; Mullol J; Sastre J; Canonica GW; Baiardini I
J Investig Allergol Clin Immunol; 2008; 18(6):426-32. PubMed ID: 19123433
[TBL] [Abstract][Full Text] [Related]
10. The impact of omalizumab on quality of life and its predictors in patients with chronic spontaneous urticaria: Real-life data.
Salman A; Demir G; Bekiroglu N
Dermatol Ther; 2019 Jul; 32(4):e12975. PubMed ID: 31145524
[TBL] [Abstract][Full Text] [Related]
11. Disease activity only moderately correlates with quality of life impairment in patients with chronic spontaneous urticaria.
Koti I; Weller K; Makris M; Tiligada E; Psaltopoulou T; Papageorgiou C; Baiardini I; Panagiotakos D; Braido F; Maurer M
Dermatology; 2013; 226(4):371-9. PubMed ID: 23942323
[TBL] [Abstract][Full Text] [Related]
12. Validation of the Turkish version of the Urticaria Control Test: Correlation with other tools and comparison between spontaneous and inducible chronic urticaria.
Kocatürk E; Kızıltaç U; Can P; Öztaş Kara R; Erdem T; Kızıltaç K; Sahillioğlu N; Gelincik A; Maurer M; Weller K
World Allergy Organ J; 2019; 12(1):100009. PubMed ID: 30937134
[TBL] [Abstract][Full Text] [Related]
13. Turkish version of the chronic urticaria quality of life questionnaire: cultural adaptation, assessment of reliability and validity.
Kocatürk E; Weller K; Martus P; Aktas S; Kavala M; Sarigul S; Baiardini I; Canonica GW; Brzoza Z; Kalogeromitros D; Maurer M
Acta Derm Venereol; 2012 Jul; 92(4):419-25. PubMed ID: 21918791
[TBL] [Abstract][Full Text] [Related]
14. Cross-cultural adaptation of the Brazilian-Portuguese version of the chronic urticaria quality-of-life questionnaire - CU-Q2oL.
Dias GA; Pires GV; Valle SO; França AT; Papi JA; Dortas SD; Levy SA; Baiardini I; Canonica GW
Allergy; 2011 Nov; 66(11):1487-93. PubMed ID: 21899558
[TBL] [Abstract][Full Text] [Related]
15. The validity and reliability of the Thai-version of 5-D itch scale.
Tuchinda P; Kulthanan K; Chularojanamontri L; Rujitharanawong C; Subchookul C; Trakanwittayarak S
Asian Pac J Allergy Immunol; 2022 Sep; 40(3):254-262. PubMed ID: 32247306
[TBL] [Abstract][Full Text] [Related]
16. Improvement in the quality of life of patients with chronic spontaneous urticaria treated with omalizumab in real life.
Larrea-Baca I; Gurpegui-Resano M
Enferm Clin; 2017; 27(6):361-368. PubMed ID: 28457893
[TBL] [Abstract][Full Text] [Related]
17. The Benefit of Complete Response to Treatment in Patients With Chronic Spontaneous Urticaria-CURE Results.
Kolkhir P; Laires PA; Salameh P; Asero R; Bizjak M; Košnik M; Dissemond J; van Doorn M; Hawro T; Kasperska-Zajac A; Zajac M; Kocatürk E; Peter J; Parisi CAS; Ritchie CA; Kulthanan K; Tuchinda P; Fomina D; Kovalkova E; Khoshkhui M; Kouzegaran S; Papapostolou N; Du-Thanh A; Kamegashira A; Meshkova R; Vitchuk A; Bauer A; Grattan C; Staubach P; Bouillet L; Giménez-Arnau AM; Maurer M; Weller K
J Allergy Clin Immunol Pract; 2023 Feb; 11(2):610-620.e5. PubMed ID: 36481420
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of Autologous Whole-Blood Injections in Patients with Refractory Chronic Spontaneous Urticaria.
Kitsioulis NA; Xepapadaki P; Roussaki-Schulze AV; Papadopoulos N; Zafiriou E
Int Arch Allergy Immunol; 2017; 172(3):161-166. PubMed ID: 28380487
[TBL] [Abstract][Full Text] [Related]
19. The Urticaria Activity Score-Validity, Reliability, and Responsiveness.
Hawro T; Ohanyan T; Schoepke N; Metz M; Peveling-Oberhag A; Staubach P; Maurer M; Weller K
J Allergy Clin Immunol Pract; 2018; 6(4):1185-1190.e1. PubMed ID: 29128337
[TBL] [Abstract][Full Text] [Related]
20. Socio-economic burden and resource utilisation in Italian patients with chronic urticaria: 2-year data from the AWARE study.
Rossi O; Piccirillo A; Iemoli E; Patrizi A; Stingeni L; Calvieri S; Gola M; Dapavo P; Cristaudo A; Zichichi L; Losappio L; Saccheri F; Pastorello EA
World Allergy Organ J; 2020 Dec; 13(12):100470. PubMed ID: 33343800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
